Therapeutic agent for hypertension

Details for Australian Patent Application No. 2006285902 (hide)

Owner SRI International

Inventors Tsuruta, Hideo

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006285902

PCT Pub. Number WO2007/026651

Priority 2005-248212 29.08.05 JP

Filing date 28 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 14 June 2012

International Classifications

C07J 5/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom

A61K 31/573 (2006.01)

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/026651 Priority application(s): WO2007/026651

25 August 2011 Assignment before Grant

  Taiho Pharmaceutical Co., Ltd. The application has been assigned to SRI International

14 June 2012 Application Accepted

  Published as AU-B-2006285902

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285915-Sulfonamide compound

2006285874-Receiver apparatus